Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Empire Bioscience's FlashTaq Hot-Start Polymerase

Premium

Empirical Bioscience this week introduced FlashTaq Hot-Start Taq DNA polymerase, a chemically-modified Taq polymerase designed to reduce non-specific amplification in PCR.

The enzyme offers fewer contamination issues and fast activation time, according to the company. Under standard hot start conditions the enzyme can be activated and it recovers both 5'-3' polymerase and 5'-exonuclease activities within two minutes versus the ten minutes of activation time required by many competing enzymes.

"Unlike traditional non-hot start Taq, which can become active at room temperature and begin to amplify non-specifically and form primer-dimers, FlashTaq will not become active until the temperature and time threshold has been reached, thus reducing the likelihood of non-specific amplification and primer-dimer formation," Pushpaja Dodla a molecular biologist with Empirical Bioscience, said in a statement.

In addition to its stability and rapid activation time, other factors help FlashTaq streamline studies, including the type of modifying reagent that it uses, Empire said. The enzyme in FlashTaq has a reduced risk of contamination because it has been chemically as opposed to antibody-modified. Enzymes that are antibody-modified are highly susceptible to contamination from the organism in which they are produced, the company said.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.